XML 66 R56.htm IDEA: XBRL DOCUMENT
v3.23.3

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands | 3 Months Ended | 6 Months Ended
--- | --- | ---
Sep. 30, 2023 USD ($) | Oct. 01, 2022 USD ($) | Sep. 30, 2023 USD ($) segment | Oct. 01, 2022 USD ($)
Segment Reporting Information [Line Items] |  |  |  |
Number of reportable segments | segment |  |  | 3 |
Net revenues before foreign exchange impact | $ 314,018 | $ 297,102 | $ 619,342 | $ 555,901
Effect of exchange rates | (880) | (5,026) | (636) | (7,504)
Net revenues | 318,183 | 297,485 | 629,515 | 558,943
Operating income | 35,303 | 46,732 | 88,962 | 77,499
Effect of exchange rates | (3,091) | (51) | (478) | 6,194
Amortization |  |  | 14,695 | 16,588
Restructuring Costs | (86) | (165) |  |
Restructuring and turnaround costs |  |  | (75) | (121)
Restructuring related costs | 1,947 | 3,029 | 4,151 | 6,551
Digital transformation costs | 3,592 | 0 | 7,297 | 0
Impairment of assets and PCS2 related charges | (552) | (83) | 411 | (267)
Intangible asset impairment | (10,419) | 0 | (10,419) | 0
Integration and transaction costs | (1,784) | (46) | (2,899) | 712
Amortization of acquired intangible assets | 7,222 | 8,221 | 14,695 | 16,588
MDR and IVDR costs | (1,988) | (2,506) | (3,154) | (5,692)
Litigation-related charges | (5,449) | (198) | (6,507) | (394)
Gain on sale of assets | 0 | 382 | 0 | 382
United States |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 236,345 | 211,724 | 473,418 | 393,720
Japan |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 15,011 | 15,129 | 26,784 | 29,007
Europe |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 38,666 | 41,850 | 78,053 | 82,307
Rest of Asia |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 27,735 | 27,861 | 49,775 | 52,285
Other |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 426 | 921 | 1,485 | 1,624
Service |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 5,045 | 5,409 | 10,809 | 10,546
Net revenues | 5,042 | 5,053 | 10,816 | 9,943
Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 141,748 | 128,888 | 280,230 | 231,930
Restructuring related costs | 74 | 108 | 243 | 748
Plasma | Plasma products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 141,900 | 127,893 | 280,510 | 230,274
Blood Center |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 68,912 | 75,652 | 136,218 | 142,225
Restructuring related costs | 28 | 16 | 73 | 18
Blood Center | Blood Center products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 68,098 | 73,683 | 135,438 | 139,377
Whole Blood, Blood Center | Blood Center products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 14,683 | 19,893 | 34,724 | 39,488
Apheresis, Blood Center | Blood Center products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 53,415 | 53,790 | 100,714 | 99,889
Hospital |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues before foreign exchange impact | 103,358 | 92,562 | 202,894 | 181,746
Restructuring related costs | 98 | 111 | 147 | 200
Hospital | Hospital products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 103,143 | 90,856 | 202,751 | 179,349
Hemostasis Management, Hospital | Hospital products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 36,998 | 34,320 | 74,818 | 67,816
Vascular Closure, Hosptial | Hospital products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 38,541 | 29,575 | 76,162 | 59,143
Other, Hopsital | Hospital products and services |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 27,604 | 26,961 | 51,771 | 52,390
Business Unit |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues | 313,141 | 292,432 | 618,699 | 549,000
Operating Segments |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 147,183 | 147,418 | 290,107 | 267,643
Operating Segments | Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 78,042 | 71,607 | 153,740 | 126,733
Operating Segments | Blood Center |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 27,307 | 37,328 | 53,590 | 67,705
Operating Segments | Hospital |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 41,834 | 38,483 | 82,777 | 73,205
Corporate |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | $ 75,750 | $ 86,769 | $ 151,059 | $ 168,353

X
- Definition Amortization of Acquired Intangible Assets + References No definition available. + Details
Name: | hae_AmortizationOfAcquiredIntangibleAssets
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Digital Transformation Costs + References No definition available. + Details
Name: | hae_DigitalTransformationCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effect of Exchange Rate on Revenues + References No definition available. + Details
Name: | hae_EffectofExchangeRateonRevenues
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effect of Exchange Rates on Operating Income + References No definition available. + Details
Name: | hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition European Medical Device Regulation Costs + References No definition available. + Details
Name: | hae_EuropeanMedicalDeviceRegulationCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Impairment Of Assets And PCS2 Related Charges (Credits) + References No definition available. + Details
Name: | hae_ImpairmentOfAssetsAndPCS2RelatedChargesCredits
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net Revenues, By Business Unit Before Foreign Exchange Impact + References No definition available. + Details
Name: | hae_NetRevenuesByBusinessUnitBeforeForeignExchangeImpact
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Operating Expenses, Transaction Costs + References No definition available. + Details
Name: | hae_OperatingExpensesTransactionCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Restructuring Related Costs + References No definition available. + Details
Name: | hae_RestructuringRelatedCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Restructuring and Turnaround Costs + References No definition available. + Details
Name: | hae_RestructuringandTurnaroundCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_GainLossOnDispositionOfAssets1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18 + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_RestructuringCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_PlasmaProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_BloodCenterProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_WholeBloodBloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_ApheresisBloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_HospitalProductsandServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_HemostasisManagementHospitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_VascularClosureHosptialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_OtherHopsitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_BusinessUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |